LIPOCINE INC (LPCN:NASDAQ)
$1.45 0.01 (0.6944%)
Analysed LIPOCINE INC (LPCN:NASDAQ) News Sources
Lipocine Announces Financial Results for the First Quarter Ended March 31, 2026
07-05-2026
yahoo.com
Lipocine to Present at A.G.P.'s Annual Virtual Healthcare Company Showcase
18-05-2026
yahoo.com
Lipocine Inc. to Host Virtual KOL Event Highlighting Unmet Needs in Postpartum Depression and the Clinical Profile of LPCN 1154
04-06-2026
yahoo.com
Lipocine to Present at the H.C. Wainwright 28th Annual Global Investment Conference
10-09-2026
yahoo.com
Lipocine (LPCN) Upgraded to Buy: What Does It Mean for the Stock?
23-09-2026
yahoo.com
Lipocine Announces Health Canada Approval of TLANDO® for Testosterone Replacement Therapy
07-10-2026
yahoo.com
LPCN Stock Is Surging: Here’s Why Lipocine Is On Traders’ Radar Today
07-10-2026
stocktwits.com
Lipocine stock surges 30% on Health Canada drug approval
07-10-2026
yahoo.com
Lipocine Health Canada Approval Clears TLANDO for Canadian Testosterone Replacement Market
07-10-2026
advfn.com
Here's Why You Should Add LPCN Stock to Your Portfolio Now
08-10-2026
yahoo.com
What is the current price of LIPOCINE INC (LPCN:NASDAQ)?
The current price of LIPOCINE INC (LPCN:NASDAQ) is $1.45.
LIPOCINE INC (LPCN:NASDAQ) absolute price change since previous trading day?
The absolute price change of LIPOCINE INC (LPCN:NASDAQ) since the previous trading day is $0.01.
LIPOCINE INC (LPCN:NASDAQ) percentage price change since previous trading day?
The percentage price change of LIPOCINE INC (LPCN:NASDAQ) since the previous trading day is 0.6944%.
What is the most recent average sentiment score for LIPOCINE INC (LPCN:NASDAQ)?
The most recent average sentiment score for LIPOCINE INC (LPCN:NASDAQ) is 77 out of 100.
What is the most recent average sentiment for LIPOCINE INC (LPCN:NASDAQ)?
The most recent sentiment for LIPOCINE INC (LPCN:NASDAQ) is .
SEC-8K** Filing Available For LIPOCINE INC (LPCN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.